Growth Capital • Life Science

CITA INVESTISSEMENT Invests In Arpida AG

On December 31, 2004, private equity firm CITA INVESTISSEMENT invested in life science company Arpida AG

Investment Context
  • This is CITA INVESTISSEMENT’s 1st transaction in the Life Science sector.
  • This is CITA INVESTISSEMENT’s 1st transaction in Switzerland.
Investment Fate
  • Arpida AG went public in 2005.

Explore All 400 Growth Capital Life Science Deals - Search the Database Free


Investment Summary

Date December 31, 2004
Target Arpida AG
Sector Life Science
Investor(s) CITA INVESTISSEMENT
Deal Type Growth Capital

Target Company

Arpida AG

Reinach, Switzerland
Biotechnology.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

CITA INVESTISSEMENT

Paris, France

Category Private Equity Firm
Founded 1985
PE ASSETS 76M EUR
Size Small
Type Sector Agnostic
DESCRIPTION

CITA INVESTISSEMENT is an investment firm focused on providing capital across various business stages. CITA will consider providing venture capital for start-ups, development capital for companies in expansion, as well as funding leveraged buyouts of mature companies. CITA does not specialize in any particular industry sector and looks primarily at the management team when evaluating opportunities. CITA will consider investing as little as $1 million in venture transactions to as much as $15 million for leveraged buyouts. CITA INVESTISSEMENT was established in 1985 and is based in Paris.


Deal Context for Investor #
Overall 11 of 27
Sector: Life Science 1 of 1
Type: Growth Capital 3 of 11
Country: Switzerland 1 of 1
Year: 2004 3 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2004-06-14 Synerway

Saint Remy-Les-Chevreuse, France

Appliance for saving and restoring data

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-01-01 Arpida AG

Reinach, Switzerland

Biotechnology.

Sell -